Pure Global AI
Colombia flag

Colombia medical device regulations

Official sources linked

INVIMA rules and guidance for medical device market access, registration, and lifecycle compliance. Each code opens a metadata page with the official source and readable HTML when available.

28 documents5 categories100% linked to official sourcesauthority INVIMA28 readable HTML
CodeRegulationCategoryEffectiveProvenance
Resolución 2025067543
2026 fee resolution — selected medical-device and IVD provisions
Complete49-page official original retained; fullphysicalpages1,35,49projected for2026medical-device/IVDvariation tariffs and commencement. All3selected legal bodies visually transcribed against scans, including completep35table withUVBcolumn andconditionalmicroenterpriseexemptions. Other-sector rows remain as original context and do not become device requirements. Full-page images retain source layout, signatures and graphic contactfooters. NoCOPconversion or universal variationroute inferred.
RegistrationJanuary 1, 2026Official
Decreto 1036/2018
Orphan, Research and Laboratory IVD Reagents
Import and commercialization rules for orphan IVDs, research-use reagents, analyte-specific reagents, and general laboratory in vitro reagents not fully covered by Decreto 3770/2004.
RegistrationJune 21, 2018Official
Decreto 581/2017
Amendments to IVD Registration and Renewal
Modifies Decreto 3770/2004. Updates automatic sanitary-registration and renewal rules for Category I and II in vitro diagnostic reagents.
RegistrationApril 4, 2017Official
Decreto 3770/2004
In Vitro Diagnostic Medical Devices Registration
Regulatory framework for in vitro diagnostic (IVD) medical devices in Colombia. Establishes IVD classification into Categories I, II, and III based on risk.
RegistrationNovember 16, 2004Official
Decreto581/2017 — INVIMA compiled expression
Decreto581 de2017 — complete INVIMA-hosted compiled expression
Complete five-page INVIMA-hosted editorial compilation of Decree581/2017. It preserves amendment, quoted IVD modification provision, subsequent-review conditions and closing publication text. Government hosting does not make it a signed Gazette facsimile. Separate from the legacy SHA-less Spanish HTML projection, whose identity and anchors remain untouched; no present consolidated-law or question-completion assertion.
Registration—Official
ASS-RSA-FM006, versión 13
Formato único de diligenciamiento de reactivos de diagnóstico in vitro — versión 13, libro Excel original completo
Complete official XLSX form workbook captured on 21 October 2026 (11 worksheets; four original controls). The source header prints an emission date of 6 November 2025; this is not asserted as a legal publication or effective date. The original XLSX is authoritative. Its read-only projection includes all worksheets, including hidden data, literal formulas and separately labelled stored values, complete original XML/relationships/control attributes, embedded original images and uninterpreted binary parts. This projection is not a facsimile, a printed-page reproduction, a completed application or a current-requirements determination; no formula, control, macro or external relationship is executed. Other versions and the older form-completion instruction expression remain separate.
Registration—Official
ASS-RSA-FM006
Instructivo para el diligenciamiento de los formularios de reactivos de diagnóstico in vitro — versión10
Complete one-page image-only official INVIMA form-completion instruction, codeASS-RSA-FM006, version10, printed emission2023-07-28. All thirteen numbered instructions, notes, original layout and institutional header are retained in the authoritative image. Native PDF text is empty; no OCR or invented transcription is supplied. The historical form version, stated submission methods and source timelines are not established as current2026 requirements or a substitute for the later version13 workbook. Source-only preservation; no facts, fee values, timing, bindings or question-completion status changes.
Registration—Official
INVIMA semantic-standard reporting instructions V6 (July 2026)
Instructivo para el manejo de la plataforma de reporte de estándar semántico —versión 6
Complete 53-page official INVIMA instructions for the semantic-standard reporting platform, printed version 6 and Bogotá, D.C., July 2026. The original explicitly covers medical devices and in vitro diagnostic reagents and retains separate templates, registration-holder and authorized-reporter roles, manufacturer/brand/reference data fields, report verification and payment workflow. This complete captured expression is distinct from the separate 17-page standard/UDI guide already held in the system. Original page images govern the unchanged native search layer, including image-only cover and back-cover institutional/contact lettering absent from native extraction. It does not establish product-registration modification requirements, approval of holder transfers, current fees or any answered-question outcome. Source-only preservation; no facts, fees, timings, bindings or question status changes.
Registration—Official
INVIMA 2026 tariff workbook — download145963
Complete official INVIMA 2026 tariff workbook — acquired download145963 expression
Complete original nine-sheet official tariff workbook, historically acquired as version5. Native projection preserves every populated cell, formulas, cell notes and validations including hidden HOME and hidden rows. It is a coordinate-preserving cell-text projection, not a facsimile of merged layout, print pagination, styles or cached formula displays. Source C4 cites23September2026 Resolution2026058314 and prior amendments. Other-sector rows, navigation shapes and logos remain original workbook context; no external links or formulas are executed. Literal MD/IVD rows are distinguishable from unrelated sectors. No new fee/currentness determination or question verification.
General—Official
INVIMA UDI user manual Version2, July2026
UDI semantic-standard and coding user manual — version 2, July 2026
Complete17-page official INVIMA user manual, version2, July2026, with every original page image retained and authoritative. Exact native PDF text is supplied only as an explicitly incomplete search layer; image-only cover/footer/timeline text and original publisher errors remain visible in original images. This guidance does not certify all Colombian variation routes or currentness of every referenced regulation.
Registration—Official
Exports carry source + retrieval date

Changes after registration in Colombia

Source-linked rules for common changes to a registered IVD. Read the scope and conditions with each rule; unverified details are listed separately.

Does changing a device brand name or logo require an update?

A change to the registered brand name and a change to logo artwork can follow different rules. The legal manufacturer, device design and intended purpose remain the same.

  • Filing route and prior approval

IVD modifications are conditional automatic decisions

Fact-level verified

Decree 581 Art. 5 replacing Decree 3770 Art. 19 provides automatic IVD-registration modifications within two days after evaluation of the submitted documents, followed by review. The applicant must demonstrate no effect on safety or effectiveness and submit the INVIMA form with supporting technical/legal documents. Basic-composition changes, reformulations or changes to initially approved product characteristics require a new registration. Later noncompliance can lead to suspension and cancellation under Art. 6.

  • Filing route and prior approval
  • Supporting documents
  • Labels and identifiers
  • Change-specific government fees

The 2026 tariff distinguishes legal, technical and combined modifications

Fact-level verified

The adopted2026 tariff lists automatic MD/IVD legal modification4001-36 at 71.55 UVB, technical4001-37 at 91.78 UVB, and combined legal/technical4001-38 at 103.99 UVB. The captured official workbook (historically acquired as V5) gives COP866,471;1,111,456;1,259,319 respectively at 2026 UVB12,110. Conditional microenterprise exemptions90116/17/18 depend on Law2069 Art. 2§2; they are not a universal zero fee.

Conditions
  • Use the actual change type: MD brand is technical whereas IVD brand is legal. The amounts are per applicable tariff event, not a worldwide portfolio quote.
  • Change-specific government fees

The current forms recognize a combined legal/technical request

Fact-level verified

Both current matrices identify legal-only4001-36, technical-only4001-37 and combined legal+technical4001-38. Select every actual requested item and provide each block’s evidence for the affected registration. This supports a combined application category, not unlimited grouping of unrelated registrations, holders or products. In the IVD form, adding information does not remove existing approved information: expressly request the intended removal/change as well.

  • Labels and identifiers

Registration changes and UDI data updates are separate acts

Fact-level verified

The July 2026 UDI manual says the transition ended8February2026 and reporting is a premarket condition from 9February2026 for authorized MD/IVD being marketed. Report the exact brand, manufacturer, model/reference/presentation and associated UDI-DI consistently with the sanitary registration. Editing a brand in the reporting interface does not approve a registration modification. These sources do not require a new UDI-DI for every internal REF change; identify the issuer-assigned DI and actual device change.

  • Change-specific review time

The IVD two-day term follows documentary evaluation

Fact-level verified

The IVD automatic-modification term is two days following evaluation of the submitted documents, with subsequent review. Decree 581 Art. 6 separately gives30 working days to respond to post-review information requests and then provides suspension/cancellation conditions; neither that cure period nor the 90-working-day initial-registration period is a variation decision term.

How do I update a manufacturer's name without changing the legal entity?

The same legal manufacturer changes its name, potentially alongside the device brand. A transfer to another legal entity is a separate question; permission to combine filings needs its own evidence.

  • Filing route and prior approval

IVD modifications are conditional automatic decisions

Fact-level verified

Decree 581 Art. 5 replacing Decree 3770 Art. 19 provides automatic IVD-registration modifications within two days after evaluation of the submitted documents, followed by review. The applicant must demonstrate no effect on safety or effectiveness and submit the INVIMA form with supporting technical/legal documents. Basic-composition changes, reformulations or changes to initially approved product characteristics require a new registration. Later noncompliance can lead to suspension and cancellation under Art. 6.

  • Filing route and prior approval
  • Supporting documents
  • Labels and identifiers

Same-person manufacturer name is a legal modification

Fact-level verified

The current modification matrix treats manufacturer corporate-name change as legal modification4001-36. For a foreign company, provide competent-origin-authority existence/name evidence, rather than a self-issued company document, or the accepted CFS showing the amended details with the required manufacturer declaration where stated. Submit labels reflecting the new manufacturer name and any applicable updated insert; do not introduce other unrequested label changes.

Conditions
  • The legal person remains the same. Actual manufacturer replacement and holder assignment use separate blocks.
  • Change-specific government fees

The 2026 tariff distinguishes legal, technical and combined modifications

Fact-level verified

The adopted2026 tariff lists automatic MD/IVD legal modification4001-36 at 71.55 UVB, technical4001-37 at 91.78 UVB, and combined legal/technical4001-38 at 103.99 UVB. The captured official workbook (historically acquired as V5) gives COP866,471;1,111,456;1,259,319 respectively at 2026 UVB12,110. Conditional microenterprise exemptions90116/17/18 depend on Law2069 Art. 2§2; they are not a universal zero fee.

Conditions
  • Use the actual change type: MD brand is technical whereas IVD brand is legal. The amounts are per applicable tariff event, not a worldwide portfolio quote.
  • Change-specific government fees
  • Combined filing

The current forms recognize a combined legal/technical request

Fact-level verified

Both current matrices identify legal-only4001-36, technical-only4001-37 and combined legal+technical4001-38. Select every actual requested item and provide each block’s evidence for the affected registration. This supports a combined application category, not unlimited grouping of unrelated registrations, holders or products. In the IVD form, adding information does not remove existing approved information: expressly request the intended removal/change as well.

  • Labels and identifiers

Registration changes and UDI data updates are separate acts

Fact-level verified

The July 2026 UDI manual says the transition ended8February2026 and reporting is a premarket condition from 9February2026 for authorized MD/IVD being marketed. Report the exact brand, manufacturer, model/reference/presentation and associated UDI-DI consistently with the sanitary registration. Editing a brand in the reporting interface does not approve a registration modification. These sources do not require a new UDI-DI for every internal REF change; identify the issuer-assigned DI and actual device change.

  • Change-specific review time

The IVD two-day term follows documentary evaluation

Fact-level verified

The IVD automatic-modification term is two days following evaluation of the submitted documents, with subsequent review. Decree 581 Art. 6 separately gives30 working days to respond to post-review information requests and then provides suspension/cancellation conditions; neither that cure period nor the 90-working-day initial-registration period is a variation decision term.

  • Free sale certificate impact

CFS depends on the actual modification block

Fact-level verified

Manufacturer name/domicile blocks permit the stated competent-authority evidence or accepted CFS alternative showing the amended details. Actual manufacturer replacement/addition has distinct CFS requirements identifying manufacturer and product/references. Product-name changes have their own supporting CFS provision. Do not infer that every brand/artwork/internal-code change needs a new CFS, or that a holder assignment alone changes the foreign manufacturer.

Conditions
  • Use the selected row’s issuance, validity, translation and legalization conditions. The legal person, product and reference mapping must be established.

What changes when the manufacturer's office address changes?

An office address change for the same legal entity, potentially alongside name and brand changes. This does not cover moving a factory or manufacturing site, and a combined filing cannot be assumed.

  • Filing route and prior approval

IVD modifications are conditional automatic decisions

Fact-level verified

Decree 581 Art. 5 replacing Decree 3770 Art. 19 provides automatic IVD-registration modifications within two days after evaluation of the submitted documents, followed by review. The applicant must demonstrate no effect on safety or effectiveness and submit the INVIMA form with supporting technical/legal documents. Basic-composition changes, reformulations or changes to initially approved product characteristics require a new registration. Later noncompliance can lead to suspension and cancellation under Art. 6.

  • Filing route and prior approval
  • Supporting documents
  • Labels and identifiers

Manufacturer domicile is a legal modification with supporting evidence

Fact-level verified

The current manufacturer-domicile block is legal modification4001-36 and requires origin-authority/company evidence or an accepted CFS reflecting the changed address, plus labels and applicable inserts showing the new domicile. The IVD address block also lists quality/sanitary certificate evidence; retain that requirement for the actual manufacturer arrangement rather than assuming an office move is a plant relocation.

Conditions
  • Identify whether the field is legal-manufacturer commercial domicile, actual manufacturing site, importer or conditioner. A production/process change requires separate assessment.
  • Change-specific government fees

The 2026 tariff distinguishes legal, technical and combined modifications

Fact-level verified

The adopted2026 tariff lists automatic MD/IVD legal modification4001-36 at 71.55 UVB, technical4001-37 at 91.78 UVB, and combined legal/technical4001-38 at 103.99 UVB. The captured official workbook (historically acquired as V5) gives COP866,471;1,111,456;1,259,319 respectively at 2026 UVB12,110. Conditional microenterprise exemptions90116/17/18 depend on Law2069 Art. 2§2; they are not a universal zero fee.

Conditions
  • Use the actual change type: MD brand is technical whereas IVD brand is legal. The amounts are per applicable tariff event, not a worldwide portfolio quote.
  • Change-specific government fees
  • Combined filing

The current forms recognize a combined legal/technical request

Fact-level verified

Both current matrices identify legal-only4001-36, technical-only4001-37 and combined legal+technical4001-38. Select every actual requested item and provide each block’s evidence for the affected registration. This supports a combined application category, not unlimited grouping of unrelated registrations, holders or products. In the IVD form, adding information does not remove existing approved information: expressly request the intended removal/change as well.

  • Labels and identifiers

Registration changes and UDI data updates are separate acts

Fact-level verified

The July 2026 UDI manual says the transition ended8February2026 and reporting is a premarket condition from 9February2026 for authorized MD/IVD being marketed. Report the exact brand, manufacturer, model/reference/presentation and associated UDI-DI consistently with the sanitary registration. Editing a brand in the reporting interface does not approve a registration modification. These sources do not require a new UDI-DI for every internal REF change; identify the issuer-assigned DI and actual device change.

  • Change-specific review time

The IVD two-day term follows documentary evaluation

Fact-level verified

The IVD automatic-modification term is two days following evaluation of the submitted documents, with subsequent review. Decree 581 Art. 6 separately gives30 working days to respond to post-review information requests and then provides suspension/cancellation conditions; neither that cure period nor the 90-working-day initial-registration period is a variation decision term.

  • Free sale certificate impact

CFS depends on the actual modification block

Fact-level verified

Manufacturer name/domicile blocks permit the stated competent-authority evidence or accepted CFS alternative showing the amended details. Actual manufacturer replacement/addition has distinct CFS requirements identifying manufacturer and product/references. Product-name changes have their own supporting CFS provision. Do not infer that every brand/artwork/internal-code change needs a new CFS, or that a holder assignment alone changes the foreign manufacturer.

Conditions
  • Use the selected row’s issuance, validity, translation and legalization conditions. The legal person, product and reference mapping must be established.

Does a catalogue or reference code change affect registration or UDI?

Check which identifier actually changes. A commercial catalogue, REF or order code is not automatically a device model, registered identifier, GTIN or UDI-DI. Rules for one identifier do not establish the route for another.

  • Filing route and prior approval

IVD modifications are conditional automatic decisions

Fact-level verified

Decree 581 Art. 5 replacing Decree 3770 Art. 19 provides automatic IVD-registration modifications within two days after evaluation of the submitted documents, followed by review. The applicant must demonstrate no effect on safety or effectiveness and submit the INVIMA form with supporting technical/legal documents. Basic-composition changes, reformulations or changes to initially approved product characteristics require a new registration. Later noncompliance can lead to suspension and cancellation under Art. 6.

  • Filing route and prior approval
  • Supporting documents
  • Labels and identifiers

IVD change/addition/exclusion of references is expressly listed

Fact-level verified

FM006v13 expressly lists change, addition or exclusion of references in the technical4001-37 K/K1/K2 block. Supply the updated insert/labels and justification requested by that block, with exact old/new details. The supporting text itself repeats presentation wording; it must not be silently rewritten into a different legal test. An order code matters only when it maps to the authorized reference/presentation.

  • Change-specific government fees

The 2026 tariff distinguishes legal, technical and combined modifications

Fact-level verified

The adopted2026 tariff lists automatic MD/IVD legal modification4001-36 at 71.55 UVB, technical4001-37 at 91.78 UVB, and combined legal/technical4001-38 at 103.99 UVB. The captured official workbook (historically acquired as V5) gives COP866,471;1,111,456;1,259,319 respectively at 2026 UVB12,110. Conditional microenterprise exemptions90116/17/18 depend on Law2069 Art. 2§2; they are not a universal zero fee.

Conditions
  • Use the actual change type: MD brand is technical whereas IVD brand is legal. The amounts are per applicable tariff event, not a worldwide portfolio quote.
  • Change-specific government fees
  • Combined filing

The current forms recognize a combined legal/technical request

Fact-level verified

Both current matrices identify legal-only4001-36, technical-only4001-37 and combined legal+technical4001-38. Select every actual requested item and provide each block’s evidence for the affected registration. This supports a combined application category, not unlimited grouping of unrelated registrations, holders or products. In the IVD form, adding information does not remove existing approved information: expressly request the intended removal/change as well.

  • Labels and identifiers

Registration changes and UDI data updates are separate acts

Fact-level verified

The July 2026 UDI manual says the transition ended8February2026 and reporting is a premarket condition from 9February2026 for authorized MD/IVD being marketed. Report the exact brand, manufacturer, model/reference/presentation and associated UDI-DI consistently with the sanitary registration. Editing a brand in the reporting interface does not approve a registration modification. These sources do not require a new UDI-DI for every internal REF change; identify the issuer-assigned DI and actual device change.

  • Change-specific review time

The IVD two-day term follows documentary evaluation

Fact-level verified

The IVD automatic-modification term is two days following evaluation of the submitted documents, with subsequent review. Decree 581 Art. 6 separately gives30 working days to respond to post-review information requests and then provides suspension/cancellation conditions; neither that cure period nor the 90-working-day initial-registration period is a variation decision term.

  • Free sale certificate impact

CFS depends on the actual modification block

Fact-level verified

Manufacturer name/domicile blocks permit the stated competent-authority evidence or accepted CFS alternative showing the amended details. Actual manufacturer replacement/addition has distinct CFS requirements identifying manufacturer and product/references. Product-name changes have their own supporting CFS provision. Do not infer that every brand/artwork/internal-code change needs a new CFS, or that a holder assignment alone changes the foreign manufacturer.

Conditions
  • Use the selected row’s issuance, validity, translation and legalization conditions. The legal person, product and reference mapping must be established.

Can several changes be filed together?

Changes to brand, manufacturer name, office address and reference codes may occur together, including with a real transfer to another legal manufacturer, registration holder or owner. Assess transfer with each single change, and transfer with brand plus reference, manufacturer name plus reference, or office address plus reference changes: seven transfer combinations in total. Evidence must establish the exact combination and the order of filings and approvals. These combinations and their sequence are not all verified by the rules below; a rule for one change does not prove that a single application, fee or review period covers the combination.

  • Combined filing
  • Filing route and prior approval
  • Change-specific government fees

The current forms recognize a combined legal/technical request

Fact-level verified

Both current matrices identify legal-only4001-36, technical-only4001-37 and combined legal+technical4001-38. Select every actual requested item and provide each block’s evidence for the affected registration. This supports a combined application category, not unlimited grouping of unrelated registrations, holders or products. In the IVD form, adding information does not remove existing approved information: expressly request the intended removal/change as well.

  • Filing route and prior approval

IVD modifications are conditional automatic decisions

Fact-level verified

Decree 581 Art. 5 replacing Decree 3770 Art. 19 provides automatic IVD-registration modifications within two days after evaluation of the submitted documents, followed by review. The applicant must demonstrate no effect on safety or effectiveness and submit the INVIMA form with supporting technical/legal documents. Basic-composition changes, reformulations or changes to initially approved product characteristics require a new registration. Later noncompliance can lead to suspension and cancellation under Art. 6.

  • Change-specific government fees

The 2026 tariff distinguishes legal, technical and combined modifications

Fact-level verified

The adopted2026 tariff lists automatic MD/IVD legal modification4001-36 at 71.55 UVB, technical4001-37 at 91.78 UVB, and combined legal/technical4001-38 at 103.99 UVB. The captured official workbook (historically acquired as V5) gives COP866,471;1,111,456;1,259,319 respectively at 2026 UVB12,110. Conditional microenterprise exemptions90116/17/18 depend on Law2069 Art. 2§2; they are not a universal zero fee.

Conditions
  • Use the actual change type: MD brand is technical whereas IVD brand is legal. The amounts are per applicable tariff event, not a worldwide portfolio quote.
  • Labels and identifiers

Registration changes and UDI data updates are separate acts

Fact-level verified

The July 2026 UDI manual says the transition ended8February2026 and reporting is a premarket condition from 9February2026 for authorized MD/IVD being marketed. Report the exact brand, manufacturer, model/reference/presentation and associated UDI-DI consistently with the sanitary registration. Editing a brand in the reporting interface does not approve a registration modification. These sources do not require a new UDI-DI for every internal REF change; identify the issuer-assigned DI and actual device change.

  • Supporting documents
  • Labels and identifiers

Same-person manufacturer name is a legal modification

Fact-level verified

The current modification matrix treats manufacturer corporate-name change as legal modification4001-36. For a foreign company, provide competent-origin-authority existence/name evidence, rather than a self-issued company document, or the accepted CFS showing the amended details with the required manufacturer declaration where stated. Submit labels reflecting the new manufacturer name and any applicable updated insert; do not introduce other unrequested label changes.

Conditions
  • The legal person remains the same. Actual manufacturer replacement and holder assignment use separate blocks.
  • Supporting documents
  • Labels and identifiers

Manufacturer domicile is a legal modification with supporting evidence

Fact-level verified

The current manufacturer-domicile block is legal modification4001-36 and requires origin-authority/company evidence or an accepted CFS reflecting the changed address, plus labels and applicable inserts showing the new domicile. The IVD address block also lists quality/sanitary certificate evidence; retain that requirement for the actual manufacturer arrangement rather than assuming an office move is a plant relocation.

Conditions
  • Identify whether the field is legal-manufacturer commercial domicile, actual manufacturing site, importer or conditioner. A production/process change requires separate assessment.
  • Supporting documents

A holder assignment requires both parties and manufacturer linkage

Fact-level verified

The holder-change block is legal modification4001-36. The assignment/acceptance may be one jointly signed document or separate consent and acceptance documents, signed by the legal representatives of assignor and assignee. Identify registration, expediente, product and brand where relevant, and provide the manufacturer/authorized party’s document establishing its relationship with the assignee. A local holder assignment is distinct from replacing a foreign manufacturer.

  • Supporting documents
  • Labels and identifiers

Actual manufacturer replacement has its own evidence block

Fact-level verified

The current manufacturer-change/addition block requires evidence that the authorized product characteristics remain unchanged, the new manufacturer’s competent-authority/QMS evidence, CFS identifying the manufacturer and product/references where applicable, updated labels/inserts, and a documented relationship between approved and new manufacturers, such as the specified manufacturing agreement, group-company proof or CFS naming the legal manufacturer and plant. It is not satisfied by a same-person name letter alone.

Conditions
  • A significant MD change or a reformulated/initial-characteristic IVD change is outside the automatic-modification route.
  • Supporting documents
  • Labels and identifiers

IVD change/addition/exclusion of references is expressly listed

Fact-level verified

FM006v13 expressly lists change, addition or exclusion of references in the technical4001-37 K/K1/K2 block. Supply the updated insert/labels and justification requested by that block, with exact old/new details. The supporting text itself repeats presentation wording; it must not be silently rewritten into a different legal test. An order code matters only when it maps to the authorized reference/presentation.

  • Supporting documents
  • Labels and identifiers
  • Change-specific review time

The IVD two-day term follows documentary evaluation

Fact-level verified

The IVD automatic-modification term is two days following evaluation of the submitted documents, with subsequent review. Decree 581 Art. 6 separately gives30 working days to respond to post-review information requests and then provides suspension/cancellation conditions; neither that cure period nor the 90-working-day initial-registration period is a variation decision term.

  • Free sale certificate impact

CFS depends on the actual modification block

Fact-level verified

Manufacturer name/domicile blocks permit the stated competent-authority evidence or accepted CFS alternative showing the amended details. Actual manufacturer replacement/addition has distinct CFS requirements identifying manufacturer and product/references. Product-name changes have their own supporting CFS provision. Do not infer that every brand/artwork/internal-code change needs a new CFS, or that a holder assignment alone changes the foreign manufacturer.

Conditions
  • Use the selected row’s issuance, validity, translation and legalization conditions. The legal person, product and reference mapping must be established.
Regulation codes

What these codes are

Each row above represents one regulatory instrument. Its code is the authority’s identifier. A regulation page collects the metadata and official source; when readable HTML is available, article links can open and highlight the exact cited passage.

Use this market context

Continue from regulations into practical research

Keep Colombia as the target market while you move into registration records, classification, cross-country product research, or pathway planning.

Keep researching this market
View the Colombia resource hub →
Compare regulations across all countries →
Tracked from official INVIMA publications · row IDs are stable — cite as regulations:colombia:decreto-1030-2007